2 338

Cited 22 times in

Supplemental Transcatheter Arterial Chemoembolization Through a Collateral Omental Artery: Treatment for Hepatocellular Carcinoma

DC FieldValueLanguage
dc.contributor.author서상현-
dc.contributor.author원정윤-
dc.contributor.author이도연-
dc.contributor.author원종윤-
dc.date.accessioned2015-07-15T16:42:38Z-
dc.date.available2015-07-15T16:42:38Z-
dc.date.issued2003-
dc.identifier.issn0174-1551-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/113443-
dc.description.abstractPURPOSE: To evaluate the therapeutic efficacy and safety of supplemental transcatheter arterial chemoembolization (TACE) through the extrahepatic collateral omental artery (OA) for the treatment of hepatocellular carcinoma (HCC). METHODS: We studied 21 patients with extrahepatic collaterals of the OA, among 1,512 patients with HCC who had undergone angiography. HCCs supplied by collateral OAs were located at: segment IV in seven, segment V in five, segment III in three, segment VI in three and segment VIII in three patients (Couinaud classification of segments). On preoperative CT scans, every HCC was abutting the liver surface. Adjacent omental infiltration or engorgement was noted in 11 patients. Celiac and hepatic arteriograms showed hypertrophy of the feeding OA in all patients. TACE of the OA was performed in 19 patients with an emulsion of iodized oil and doxorubicin hydrochloride. Embolization with gelatin sponge particles was added in five patients. RESULTS: Collaterals of the OA to the HCC were found on the first to seventeenth sessions of TACE. On follow-up CT scans, five patients showed complete uptake of iodized oil in the tumor. Partial uptake of iodized oil was noted in 13 patients and no uptake in one patient. There was no serious complication that related to the omental embolization, such as omental or bowel ischemia. The cumulative survival rates from the time of the TACE of the OA were 81% at 6 months and 68% at 12 months. CONCLUSION: TACE of the OA is safe and has a potential therapeutic effect in the treatment of HCC.-
dc.description.statementOfResponsibilityopen-
dc.format.extent136~140-
dc.relation.isPartOfCARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAged-
dc.subject.MESHAntibiotics, Antineoplastic/administration & dosage-
dc.subject.MESHCarcinoma, Hepatocellular/diagnosis-
dc.subject.MESHCarcinoma, Hepatocellular/mortality-
dc.subject.MESHCarcinoma, Hepatocellular/therapy*-
dc.subject.MESHCatheters, Indwelling-
dc.subject.MESHChemoembolization, Therapeutic*-
dc.subject.MESHCollateral Circulation/drug effects-
dc.subject.MESHContrast Media/administration & dosage-
dc.subject.MESHContrast Media/metabolism-
dc.subject.MESHDisease Progression-
dc.subject.MESHDoxorubicin/administration & dosage-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHGastroepiploic Artery/surgery-
dc.subject.MESHHepatic Artery/diagnostic imaging-
dc.subject.MESHHepatic Artery/surgery-
dc.subject.MESHHumans-
dc.subject.MESHIodized Oil/administration & dosage-
dc.subject.MESHIodized Oil/metabolism-
dc.subject.MESHKorea-
dc.subject.MESHLiver Neoplasms/diagnosis-
dc.subject.MESHLiver Neoplasms/mortality-
dc.subject.MESHLiver Neoplasms/therapy*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOmentum/blood supply*-
dc.subject.MESHOmentum/diagnostic imaging-
dc.subject.MESHOmentum/pathology-
dc.subject.MESHSurvival Analysis-
dc.subject.MESHTomography, X-Ray Computed-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHalpha-Fetoproteins/administration & dosage-
dc.titleSupplemental Transcatheter Arterial Chemoembolization Through a Collateral Omental Artery: Treatment for Hepatocellular Carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiology (영상의학)-
dc.contributor.googleauthorJong Yun Won-
dc.contributor.googleauthorDo Yun Lee-
dc.contributor.googleauthorSang Joon Park-
dc.contributor.googleauthorSang-Hyun Suh-
dc.contributor.googleauthorHyung Sik Yoo-
dc.contributor.googleauthorMyeong-Jin Kim-
dc.contributor.googleauthorSung Il Park-
dc.contributor.googleauthorJong Tae Lee-
dc.identifier.doi10.1007/s00270-002-2629-y-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02443-
dc.contributor.localIdA01886-
dc.contributor.localIdA02718-
dc.relation.journalcodeJ00459-
dc.identifier.eissn1432-086X-
dc.identifier.pmid12638036-
dc.identifier.urlhttp://link.springer.com/article/10.1007%2Fs00270-002-2629-y-
dc.subject.keywordLiver neopla는-
dc.subject.keywordchemotherapeutic infusion Liver neopla는-
dc.subject.keywordblood supply Hepatic arteries-
dc.subject.keywordchemotherapeutic infusion-
dc.contributor.alternativeNameSuh, Sang Hyun-
dc.contributor.alternativeNameWon, Jong Yun-
dc.contributor.alternativeNameLee, Do Yun-
dc.contributor.affiliatedAuthorWon, Jong Yun-
dc.contributor.affiliatedAuthorSuh, Sang Hyun-
dc.contributor.affiliatedAuthorLee, Do Yun-
dc.rights.accessRightsnot free-
dc.citation.volume26-
dc.citation.number2-
dc.citation.startPage136-
dc.citation.endPage140-
dc.identifier.bibliographicCitationCARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, Vol.26(2) : 136-140, 2003-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.